$CL · Colgate-Palmolive Company
Latest call · 2026-04-23
The call
Head-to-head · Claude vs the Street vs reality
| Claude | Street | Actual | |
|---|---|---|---|
| EPS | $0.96 | $0.95 | ⏳ pending |
| Revenue | $4.90B | $4.89B | — |
| Direction (1d) | 🟡 FLAT |
🟡 FLAT
11B · 13H · 1S
|
— |
| 1d move | +0.5% | — | — |
| 3d move | +1.0% | — | — |
Thesis
Boring is the call. Four-for-four beat history with a 4.4% average surprise — staples prints are mechanical and the median 1-day reaction is sub-1%. Estimate revisions essentially flat, Hill's Pet quietly compounding at 6-7%, LatAm FX drag easing — the setup is no-news-is-good-news.
What would flip it
Organic sales below +3% on volume slippage would crack the price-led story; tariff commentary on the call is the wildcard.
The market's narrative
Defensive staple, low-vol compounder. Topline carried by pricing > volume in LatAm + Hill's pet, with FX a recurring drag. The print is rarely a story unless organic sales surprise either way by 200+ bps.
Where the Street may be wrong
- Estimate revisions essentially flat (-0.23% in 30 days) = consensus is already calibrated to the business; this is a no-news-is-good-news quarter.
- Hill's Pet Nutrition organic growth has been the silent compounder — running ~6-7%/qtr against a Pet Food sector that printed ~3% across peers (CHWY data). Not in the bear thesis.
- LatAm FX (BRL, MXN) stabilized in Q1 vs Q4's volatility — translation drag should be ~150 bps less of a hit than Q4's transcript flagged.
Peer read: PG reports next week — CL is the staples-quality bellwether that PG follows, not the other way. UL Q1 trading update on April 17 showed continued price-led growth with stable volume — supportive backdrop for CL's pricing > volume mix.
Reasoning
- Track record: 4-for-4 beats but avg surprise only +4.4% — staples beats are mechanical and small. Reaction is mechanical and small too. Median 1d move on a CL print is ±0.8%.
- Stock 4% below EMA50/200 cross at $86.03 — slight technical weakness, not a breakdown. Consistent with low-vol staples compression in a risk-on tape.
- Per the BOH lesson (technical ceiling = FLAT bias): there's no momentum, no positioning extreme, no obvious story. FLAT with mild upward bias is the honest call.
- Avg PT ~$95 vs spot $82.35 = +15% upside but staples re-rate slowly — a single-quarter print rarely drives 15% gap moves. This is a 12-month thesis stock.
- Confidence MEDIUM because the magnitude is conservative; direction is FLAT-to-slight-up which has the highest base rate for staples post-print.
Risks to the call
- Organic sales below +3% (vs the +5-6% normal range) on volume slip — confirms volume-elasticity worry on price increases and sells off -2-3%.
- Trump/tariff commentary on the call about LatAm/China exposure — staples management voicing tariff risk has been the new earnings-day idiosyncratic risk in 2026.